Quarterly report pursuant to Section 13 or 15(d)

Liquidity - Additional information (Detail)

v3.24.1.1.u2
Liquidity - Additional information (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Apr. 18, 2024
Aug. 11, 2023
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Mar. 31, 2024
Mar. 31, 2023
Oct. 17, 2023
Sep. 15, 2022
Net loss     $ (4,279) $ (6,798) $ (5,954) $ (4,397) $ (5,411) $ (5,093) $ (17,031) $ (14,901)    
Net cash used in provided by operations                 (16,110) $ (13,917)    
Cash and cash equivalents     $ 14,100           $ 14,100      
Warrants exercise price                       $ 11.22
Sale of stock issue price per share   $ 1.9299                    
Subsequent Event [Member]                        
Sale of stock issue price per share $ 4.8                      
Sale of stock number of shares issued in the transaction 5,749,152                      
Pre-funded warrants [Member]                        
Warrants exercise price   0.0001                 $ 0.0001  
Sale of stock issue price per share   $ 1.9298                    
Sale of stock number of shares issued in the transaction   15,126,226                    
Pre-funded warrants [Member] | Subsequent Event [Member]                        
Gross proceeds from issuance of warrants $ 40,000                      
Warrants exercise price $ 0.0001                      
Class of warrant purchase price per warrant $ 4.7999                      
Warrants convertible into shares of common stock on exercise 2,584,239